Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COMT Genotype and Response to Cognitive Remediation in Schizophrenia

NCT00664274 is registered in ClinicalTrials.gov with Manhattan Psychiatric Center as lead sponsor.

NCT NCT00664274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00664274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COMT Genotype and Response to Cognitive Remediation in Schizophrenia
Lead sponsor
Manhattan Psychiatric Center
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2007
Completion date
October 31, 2016
Enrollment
142 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic schizophrenia